Stoutjesdijk M J, Boetes C, Jager G J, Beex L, Bult P, Hendriks J H, Laheij R J, Massuger L, van Die L E, Wobbes T, Barentsz J O
Department of Radiology, University Medical Center St Radboud, Nijmegen, The Netherlands.
J Natl Cancer Inst. 2001 Jul 18;93(14):1095-102. doi: 10.1093/jnci/93.14.1095.
Although breast cancer screening is recommended to start at a younger age for women with a hereditary risk of breast cancer, the sensitivity of mammography for these women is reduced. We compared magnetic resonance imaging (MRI) with mammography to determine which is more sensitive and whether MRI could play a role in the early detection of breast cancer for these women.
We constructed a retrospective cohort of all breast MRI and mammography surveillance reports made in our department from November 1994 to February 2001. All of the 179 women in the cohort had received biannual palpation in addition to annual imaging by MRI, mammography, or both. The 258 MRI images and the 262 mammograms were classified with the use of the BI-RADS (i.e., Breast Imaging Reporting and Data System) scoring system, which has five categories to indicate the level of suspicion of a lesion. Receiver operator characteristic curves were generated for MRI and mammography, and the area under each curve (AUC) was assessed for the entire cohort of 179 women and for a subset of 75 women who had received both an MRI and a mammographic examination within a 4-month period. All statistical tests were two-sided.
In the cohort of 179 women, we detected 13 breast cancers. Seven cancers were not revealed by mammography, but all were detected by MRI. For the entire cohort, the AUC for mammography was 0.74 (95% confidence interval [CI] = 0.68 to 0.79), and the AUC for MRI was 0.99 (95% CI = 0.98 to 1.0). For the subset of women who had both examinations, the AUC for mammography was 0.70 (95% CI = 0.60 to 0.80), and the AUC for MRI was 0.98 (95% CI = 0.95 to 1.0).
MRI was more accurate than mammography in annual breast cancer surveillance of women with a hereditary risk of breast cancer. Larger prospective studies to examine the role of MRI in screening programs are justified.
尽管对于有乳腺癌遗传风险的女性,建议在更年轻时开始进行乳腺癌筛查,但乳腺钼靶对这些女性的敏感性会降低。我们比较了磁共振成像(MRI)和乳腺钼靶,以确定哪种检查更敏感,以及MRI是否能在这些女性乳腺癌的早期检测中发挥作用。
我们构建了一个回顾性队列,纳入了1994年11月至2001年2月在我们科室进行的所有乳腺MRI和乳腺钼靶监测报告。该队列中的179名女性除了每年接受MRI、乳腺钼靶或两者检查外,还每半年接受一次触诊。使用BI-RADS(即乳腺影像报告和数据系统)评分系统对258幅MRI图像和262幅乳腺钼靶图像进行分类,该系统有五个类别来表明病变的可疑程度。为MRI和乳腺钼靶生成了受试者操作特征曲线,并对179名女性的整个队列以及在4个月内同时接受了MRI和乳腺钼靶检查的75名女性子集评估了每条曲线下的面积(AUC)。所有统计检验均为双侧检验。
在179名女性队列中,我们检测到13例乳腺癌。7例癌症乳腺钼靶未检测到,但MRI均检测到。对于整个队列,乳腺钼靶的AUC为0.74(95%置信区间[CI]=0.68至0.79),MRI的AUC为0.99(95%CI=0.98至1.0)。对于同时接受两种检查的女性子集,乳腺钼靶的AUC为0.70(95%CI=0.60至0.80),MRI的AUC为0.98(95%CI=0.95至1.0)。
在对有乳腺癌遗传风险的女性进行年度乳腺癌监测中,MRI比乳腺钼靶更准确。开展更大规模的前瞻性研究以检验MRI在筛查项目中的作用是合理的。